When Substrate Meets Device: ICD Implantation and Therapy across the Spectrum of Cardiomyopathies
ICD therapy in cardiomyopathies must be individualized, balancing arrhythmic protection against disease-specific risks and device-related complications. Tailored programming, careful system selection, and remote monitoring are key to improving outcomes. Emerging technologies such as modular and extravascular ICD systems promise safer and more phenotype-driven care.
Authors
- Francesco Notaristefano (ORCID: https://orcid.org/0000-0003-0904-6577)
- Andrea Cardona (ORCID: https://orcid.org/0000-0003-2610-8979)
- Ludovico Lazzari (ORCID: https://orcid.org/0000-0002-9382-840X)
- Chiara Andreoli (ORCID: https://orcid.org/0000-0003-2500-385X)
- Nicolò Sisti (ORCID: https://orcid.org/0000-0003-1795-855X)
- Giovanni Carreras
- Amato Santoro
- Federico Fortuni
Institutions
- University of Siena (IT)
- University of Perugia (IT)
- Santa Maria Nuova Hospital (IT)
- State Administration of Foreign Experts Affairs (CN)
- Azienda Ospedaliera di Perugia (IT)
- Azienda Ospedaliero Universitaria San Giovanni Battista (IT)
- Advanced Cell Diagnostics (United States) (US)
Publication Details
- Journal
- Pacing and Clinical Electrophysiology
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1111/pace.70149
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00